help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Handelsman, D. J.
Right arrow Articles by Mackey, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Handelsman, D. J.
Right arrow Articles by Mackey, M. A.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 4113-4121, Copyright © 1996 by Endocrine Society

ARTICLES

Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot

DJ Handelsman, AJ Conway, CJ Howe, L Turner and MA Mackey
Andrology Unit, Royal Prince Alfred Hospital, New South Wales, Australia. djh@med.su.oz.au

Hormonally induced azoospermia induced by weekly im injections of testosterone enanthate provides effective and reversible male contraception, but more practical regimens are needed. Given our previous findings that six 200-mg pellets implanted subdermally produced more stable, physiological T levels and reduced the delivered T dose by more than 50% while maintaining equally effective suppression of sperm output with fewer metabolic side-effects than weekly 200-mg testosterone enanthate injections, we sought in this study to determine 1) whether further dose-sparing could be achieved by lower testosterone doses while maintaining efficacy and 2) the efficacy of adding a depot progestin to a suboptimally suppressive depot testosterone dose as a model depot progestin/androgen combination male contraceptive. Healthy volunteers were randomized into groups (n = 10) who received either of two lower T doses (two or four 200-mg T pellets) or four 200-mg T pellets plus a single im injection of 300 mg depot medroxyprogesterone acetate (DMPA). Two T pellets (400 mg, 3 mg/day) had a negligible effect on sperm output. Four T pellets (800 mg, 6 mg/day) suppressed sperm output between the second to fourth postimplant months; output returned to normal by the seventh postimplant month, although only 4 of 10 men became azoospermic or severely oligozoospermic (< 3 mol/L/mL). The addition of a depot progestin markedly increased the extent, but not the rate, of sperm output suppression, with 9 of 10 becoming azoospermic and 10 of 10 becoming severely oligozoospermic. There were no serious adverse effects during the study. Plasma total and free testosterone levels remained within the eugonadal range at all times with each treatment. Plasma epitestosterone was suppressed by all 3 regimens, consistent with a dose-dependent inhibition of endogenous Leydig cell steroidogenesis. Plasma LH and FSH measured by a two-site immunoassay were suppressed in a dose-dependent fashion by T and further suppressed by the addition of DMPA. Sex hormone-binding globulin levels were decreased by DMPA, but not by either T dose. Prostate-specific antigen and lipids (total, low or high density lipoprotein cholesterol, and triglycerides) were not significantly changed in any group. Thus, a depot testosterone preparation with zero order release must be delivered at between 6-9 mg/day to provide optimal (but not uniform) efficacy at inducing azoospermia. The addition of a single depot dose of a progestin to a suboptimal testosterone dose (6 mg/day) markedly enhances the extent, but not the rate, of spermatogenic suppression, with negligible biochemical androgenic side-effects. These findings provide a basis for the use of a progestin/androgen combination depot for hormonal male contraception.


This article has been cited by other articles:


Home page
 J AndrolHome page
M. J. Walton, N. Kumar, D. T. Baird, H. Ludlow, and R. A. Anderson
7{alpha}-Methyl-19-Nortestosterone (MENT) vs Testosterone in Combination With Etonogestrel Implants for Spermatogenic Suppression in Healthy Men
J Androl, September 1, 2007; 28(5): 679 - 688.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. T. Page, J. K. Amory, B. D. Anawalt, M. S. Irwig, A. T. Brockenbrough, A. M. Matsumoto, and W. J. Bremner
Testosterone Gel Combined with Depomedroxyprogesterone Acetate Is an Effective Male Hormonal Contraceptive Regimen and Is Not Enhanced by the Addition of a GnRH Antagonist
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4374 - 4380.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. J. Walton, R. A. L. Bayne, I. Wallace, D. T. Baird, and R. A. Anderson
Direct Effect of Progestogen on Gene Expression in the Testis during Gonadotropin Withdrawal and Early Suppression of Spermatogenesis
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2526 - 2533.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
K. L. Matthiesson and R. I. McLachlan
Male hormonal contraception: concept proven, product in sight?
Hum. Reprod. Update, July 1, 2006; 12(4): 463 - 482.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Wang, X. H. Wang, A. L. Nelson, K. K. Lee, Y. G. Cui, J. S. Tong, N. Berman, L. Lumbreras, A. Leung, L. Hull, et al.
Levonorgestrel Implants Enhanced the Suppression of Spermatogenesis by Testosterone Implants: Comparison between Chinese and Non-Chinese Men
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 460 - 470.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Y. Lue, C. Wang, Y.-X. Liu, A. P. S. Hikim, X.-S. Zhang, C.-M. Ng, Z.-Y. Hu, Y.-C. Li, A. Leung, and R. S. Swerdloff
Transient Testicular Warming Enhances the Suppressive Effect of Testosterone on Spermatogenesis in Adult Cynomolgus Monkeys (Macaca fascicularis)
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 539 - 545.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
B.M. Brady, J.K. Amory, A. Perheentupa, M. Zitzmann, C.J. Hay, D. Apter, R.A. Anderson, W.J. Bremner, P. Pollanen, E. Nieschlag, et al.
A multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive
Hum. Reprod., January 1, 2006; 21(1): 285 - 294.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. N. Zhuang, L. P. Ly, R. G. Cumming, and D. J. Handelsman
Growth and Development during Early Manhood as Determinants of Prostate Size in Later Life
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6055 - 6063.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. V. Marcell, K. Plowden, and S. M. Bowman
Exploring older adolescents' and young adults' attitudes regarding male hormonal contraception: applications for clinical practice
Hum. Reprod., November 1, 2005; 20(11): 3078 - 3084.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
C. Garrett, D.Y. Liu, R.I. McLachlan, and H.W.G. Baker
Time course of changes in sperm morphometry and semen variables during testosterone-induced suppression of human spermatogenesis
Hum. Reprod., November 1, 2005; 20(11): 3091 - 3100.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. L. Matthiesson, P. G. Stanton, L. O'Donnell, S. J. Meachem, J. K. Amory, R. Berger, W. J. Bremner, and R. I. McLachlan
Effects of Testosterone and Levonorgestrel Combined with a 5{alpha}-Reductase Inhibitor or Gonadotropin-Releasing Hormone Antagonist on Spermatogenesis and Intratesticular Steroid Levels in Normal Men
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5647 - 5655.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. P. Ly, P. Y. Liu, and D. J. Handelsman
Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens
Hum. Reprod., June 1, 2005; 20(6): 1733 - 1740.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. J. Hay, B. M. Brady, M. Zitzmann, K. Osmanagaoglu, P. Pollanen, D. Apter, F. C. W. Wu, R. A. Anderson, E. Nieschlag, P. Devroey, et al.
A Multicenter Phase IIb Study of a Novel Combination of Intramuscular Androgen (Testosterone Decanoate) and Oral Progestogen (Etonogestrel) for Male Hormonal Contraception
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2042 - 2049.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
L. P Ly and D. J Handelsman
Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays
Eur. J. Endocrinol., March 1, 2005; 152(3): 471 - 478.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
K. Heinemann, F. Saad, M. Wiesemes, and L. A. J. Heinemann
Expectations Toward a Novel Male Fertility Control Method and Potential User Types: Results of a Multinational Survey
J Androl, March 1, 2005; 26(2): 155 - 162.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
K. Heinemann, F. Saad, M. Wiesemes, S. White, and L. Heinemann
Attitudes toward male fertility control: results of a multinational survey on four continents
Hum. Reprod., February 1, 2005; 20(2): 549 - 556.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. L. Matthiesson, J. K. Amory, R. Berger, A. Ugoni, R. I. McLachlan, and W. J. Bremner
Novel Male Hormonal Contraceptive Combinations: The Hormonal and Spermatogenic Effects of Testosterone and Levonorgestrel Combined with a 5{alpha}-Reductase Inhibitor or Gonadotropin-Releasing Hormone Antagonist
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 91 - 97.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
B.M. Brady, M. Walton, N. Hollow, A.T. Kicman, D.T. Baird, and R.A. Anderson
Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception
Hum. Reprod., November 1, 2004; 19(11): 2658 - 2667.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Shetty, C. C. Y. Weng, O. U. Bolden-Tiller, I. Huhtaniemi, D. J. Handelsman, and M. L. Meistrich
Effects of Medroxyprogesterone and Estradiol on the Recovery of Spermatogenesis in Irradiated Rats
Endocrinology, October 1, 2004; 145(10): 4461 - 4469.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
Y.-L. Gui, C.-H. He, J. K. Amory, W. J. Bremner, E-X. Zheng, J. Yang, P.-J. Yang, and E.-S. Gao
Male Hormonal Contraception: Suppression of Spermatogenesis by Injectable Testosterone Undecanoate Alone or With Levonorgestrel Implants in Chinese Men
J Androl, September 1, 2004; 25(5): 720 - 727.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Kelleher, A. J. Conway, and D. J. Handelsman
Blood Testosterone Threshold for Androgen Deficiency Symptoms
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3813 - 3817.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Y.-q. Gu, J.-s. Tong, D.-z. Ma, X.-h. Wang, D. Yuan, W.-h. Tang, and W. J. Bremner
Male Hormonal Contraception: Effects of Injections of Testosterone Undecanoate and Depot Medroxyprogesterone Acetate at Eight-Week Intervals in Chinese Men
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2254 - 2262.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. I. McLachlan, D. M. Robertson, E. Pruysers, A. Ugoni, A. M. Matsumoto, B. D. Anawalt, W. J. Bremner, and C. Meriggiola
Relationship between Serum Gonadotropins and Spermatogenic Suppression in Men Undergoing Steroidal Contraceptive Treatment
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 142 - 149.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. C. Meriggiola, A. Costantino, S. Cerpolini, W. J. Bremner, D. Huebler, A. M. Morselli-Labate, B. Kirsch, A. Bertaccini, C. Pelusi, and G. Pelusi
Testosterone Undecanoate Maintains Spermatogenic Suppression Induced by Cyproterone Acetate Plus Testosterone Undecanoate in Normal Men
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5818 - 5826.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Turner, A. J. Conway, M. Jimenez, P. Y. Liu, E. Forbes, R. I. McLachlan, and D. J. Handelsman
Contraceptive Efficacy of a Depot Progestin and Androgen Combination in Men
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4659 - 4667.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
M. C. Meriggiola, T. M.M. Farley, and M. T. Mbizvo
A Review of Androgen-Progestin Regimens for Male Contraception
J Androl, July 1, 2003; 24(4): 466 - 483.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
K. L. Matthiesson, D. M. Robertson, H. G. Burger, and R. I. McLachlan
Response of serum inhibin B and pro-{alpha}C levels to gonadotrophic stimulation in normal men before and after steroidal contraceptive treatment
Hum. Reprod., April 1, 2003; 18(4): 734 - 743.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
W.M. Hair, F. C.W. Wu, and G. A. Lincoln
An investigation of the effectiveness of testosterone implants in combination with the prolactin inhibitor quinagolide in the suppression of spermatogenesis in men
Hum. Reprod., April 1, 2003; 18(4): 749 - 755.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Y.-Q. Gu, X.-H. Wang, D. Xu, L. Peng, L.-F. Cheng, M.-K. Huang, Z.-J. Huang, and G.-Y. Zhang
A Multicenter Contraceptive Efficacy Study of Injectable Testosterone Undecanoate in Healthy Chinese Men
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 562 - 568.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R. A. Anderson and D. T. Baird
Male Contraception
Endocr. Rev., December 1, 2002; 23(6): 735 - 762.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R.A. Anderson, Z.M. van der Spuy, O.A. Dada, S.K. Tregoning, P.M. Zinn, O.A. Adeniji, T.A. Fakoya, K.B. Smith, and D.T. Baird
Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone
Hum. Reprod., November 1, 2002; 17(11): 2869 - 2877.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
M. C. Meriggiola, A. Costantino, W. J. Bremner, and A. M. Morselli-Labate
Higher Testosterone Dose Impairs Sperm Suppression Induced by a Combined Androgen-Progestin Regimen
J Androl, September 1, 2002; 23(5): 684 - 690.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. T. G. Gonzalo, R. S. Swerdloff, A. L. Nelson, B. Clevenger, R. Garcia, N. Berman, and C. Wang
Levonorgestrel Implants (Norplant II) for Male Contraception Clinical Trials: Combination with Transdermal and Injectable Testosterone
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3562 - 3572.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. A. Anderson, D. Kinniburgh, and D. T. Baird
Suppression of Spermatogenesis by Etonogestrel Implants with Depot Testosterone: Potential for Long-Acting Male Contraception
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3640 - 3649.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Y. Liu, S. M. Wishart, and D. J. Handelsman
A Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Recombinant Human Chorionic Gonadotropin on Muscle Strength and Physical Function and Activity in Older Men with Partial Age-Related Androgen Deficiency
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3125 - 3135.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
D. Kinniburgh, H. Zhu, L. Cheng, A.T. Kicman, D.T. Baird, and R.A. Anderson
Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men
Hum. Reprod., June 1, 2002; 17(6): 1490 - 1501.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. C. Meriggiola, W. J. Bremner, A. Costantino, A. Bertaccini, A. M. Morselli-Labate, D. Huebler, G. Kaufmann, M. Oettel, and C. Flamigni
Twenty-One Day Administration of Dienogest Reversibly Suppresses Gonadotropins and Testosterone in Normal Men
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2107 - 2113.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. I. McLachlan, L. O'Donnell, P. G. Stanton, G. Balourdos, M. Frydenberg, D. M. de Kretser, and D. M. Robertson
Effects of Testosterone Plus Medroxyprogesterone Acetate on Semen Quality, Reproductive Hormones, and Germ Cell Populations in Normal Young Men
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 546 - 556.
[Abstract] [Full Text] [PDF]

Home page
 Recent Prog Horm ResHome page
R.I. McLachlan, L. O'Donnell, S.J. Meachem, P.G. Stanton, D.M. de Kretser, K. Pratis, and D.M. Robertson
Identification of Specific Sites of Hormonal Regulation in Spermatogenesis in Rats, Monkeys, and Man
Recent Prog. Horm. Res., January 1, 2002; 57(1): 149 - 179.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. M. Hair, K. Kitteridge, D. B. O'Connor, and F. C. W. Wu
A Novel Male Contraceptive Pill-Patch Combination: Oral Desogestrel and Transdermal Testosterone in the Suppression of Spermatogenesis in Normal Men
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5201 - 5209.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. P. Ly, M. Jimenez, T. N. Zhuang, D. S. Celermajer, A. J. Conway, and D. J. Handelsman
A Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Transdermal Dihydrotestosterone Gel on Muscular Strength, Mobility, and Quality of Life in Older Men with Partial Androgen Deficiency
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4078 - 4088.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. Yu and D. J. Handelsman
Pharmacogenetic Polymorphisms of the AR and Metabolism and Susceptibility to Hormone- Induced Azoospermia
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4406 - 4411.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. A. Sader, K. A. Griffiths, R. J. McCredie, D. J. Handelsman, and D. S. Celermajer
Androgenic anabolic steroids and arterial structure and function in male bodybuilders
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 224 - 230.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
C. W. Martin, S. C. Riley, D. Everington, N. P. Groome, R. A. Riemersma, D. T. Baird, and R. A. Anderson
Dose-finding study of oral desogestrel with testosterone pellets for suppression of the pituitary-testicular axis in normal men
Hum. Reprod., July 1, 2000; 15(7): 1515 - 1524.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
C.W. Martin, R.A. Anderson, L. Cheng, P.C. Ho, Z. van derSpuy, K.B. Smith, A.F. Glasier, D. Everington, and D.T. Baird
Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations
Hum. Reprod., March 1, 2000; 15(3): 637 - 645.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
D. J. Handelsman, S. Wishart, and A. J. Conway
Oestradiol enhances testosterone-induced suppression of human spermatogenesis
Hum. Reprod., March 1, 2000; 15(3): 672 - 679.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G.-y. Zhang, Y.-q. Gu, X.-h. Wang, Y.-g. Cui, and W. J. Bremner
A Clinical Trial of Injectable Testosterone Undecanoate as a Potential Male Contraceptive in Normal Chinese Men
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3642 - 3647.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
G. Noe, J. Suvisaari, C. Martin, A.J. Moo-Young, K. Sundaram, S.I. Saleh, E. Quintero, H.B. Croxatto, and P. Lahteenmaki
Gonadotrophin and testosterone suppression by 7{alpha}-methyl-19-nortestosterone acetate administered by subdermal implant to healthy men
Hum. Reprod., September 1, 1999; 14(9): 2200 - 2206.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
P. Y. Liu, L. Turner, D. Rushford, J. McDonald, H.W.G. Baker, A. J. Conway, and D. J. Handelsman
Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men
Hum. Reprod., June 1, 1999; 14(6): 1540 - 1545.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. C. W. Wu, R. Balasubramanian, T. M. T. Mulders, and H. J. T. Coelingh-Bennink
Oral Progestogen Combined with Testosterone as a Potential Male Contraceptive: Additive Effects between Desogestrel and Testosterone Enanthate in Suppression of Spermatogenesis, Pituitary-Testicular Axis, and Lipid Metabolism
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 112 - 122.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
Y. Zhengwei, N. G. Wreford, P. Royce, D. M. de Kretser, and R. I. McLachlan
Stereological Evaluation of Human Spermatogenesis after Suppression by Testosterone Treatment: Heterogeneous Pattern of Spermatogenic Impairment
J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1284 - 1291.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. J. Giltay, E. K. Hoogeveen, J. M. H. Elbers, L. J. G. Gooren, H. Asscheman, and C. D. A. Stehouwer
Effects of Sex Steroids on Plasma Total Homocysteine Levels: A Study in Transsexual Males and Females
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 550 - 553.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society